A phase I study to determine the safety, tolerability and maximum tolerated dose of green-lipped mussel (Perna canaliculus) lipid extract, in patients with advanced prostate and breast cancer

Annals of Oncology

Volumn 21, Issue 5, 2009, Pages 1089-1093

  Sukumaran, S ^a   Pittman, K B ^a   Patterson, W K ^a   Dickson, J ^a   Yeend, S ^a   Townsend, A ^a   Broadbridge, V ^a   Price, T J ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Breast cancer; Green lipped mussel; Lyprinol; Prostate cancer

Indexed keywords

LYPRINOL; PROSTATE SPECIFIC ANTIGEN;

ABDOMINAL PAIN; ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER RADIOTHERAPY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DRUG DOSE ESCALATION; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; FEMALE; HUMAN; LETHARGY; LIVER DYSFUNCTION; MALE; MAXIMUM TOLERATED DOSE; MUSSEL; NAUSEA AND VOMITING; PERNA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SIDE EFFECT; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 77953327190     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp420     Document Type: Article

References (17)

1. Gao X, Grignon DJ, Chbihi T et al. Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer. Urology 1995; 46: 227-237.
2. Gao X, Porter AT, Honn KV. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications. Adv Exp Med Biol 1997; 407: 41-53.
3. Anderson KM, Seed T, Ondrey F et al. The selective 5-lipoxygenase inhibitor A63162 reduces PC3 proliferation and initiates morphologic changes consistent with secretion. Anticancer Res 1994; 14: 1951-1960.
4. Anderson KM, Seed T, Vos M et al. 5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate non-necrotic cell death. Prostate 1998; 37: 161-173.
5. Ghosh J, Myers CE. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 1997; 235: 418-423.
6. Ghosh J, Myers CE. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc Natl Acad Sci U S A 1998; 95: 13182-13187.
7. Li L, Zhu Z, Joshi B et al. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: in vitro studies. Anticancer Res 1999; 19: 51-60.
8. Liu B, Maher RJ, De Jonckheere JP et al. 12(S)-HETE increases the motility of prostate tumor cells through selective activation of PKC alpha. Adv Exp Med Biol 1997; 400B: 707-718.
9. Liu B, Maher RJ, Hannun YA et al. 12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha. J Natl Cancer Inst 1994; 86(15): 1145-1151.
10. Myers CE, Ghosh J. Lipoxygenase inhibition in prostate cancer. Eur Urol 1999; 35: 395-398.
11. Tang DG, Li L, Zhu Z et al. BMD188, a novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases. Pathol Oncol Res 1998; 4(3): 179-190.
12. Nie D, Hillman GG, Geddes T et al. Platelet-type 12-lipoxygenase in a human prostate carcinoma stimulates angiogenesis and tumor growth. Cancer Res 1998; 58: 4047-4051.
13. Whitehouse MW, Macrides TA, Kalafatis N et al. Anti-inflammatory activity of a lipid fraction (Lyprinol) from the NZ green-lipped mussel. Inflammopharmacology 1997; 5: 237-246.
14. Zhang C, Betts W, Chai F et al. Lyprinol, a lipid extract from the New Zealand green-lipped mussel, is a lipoxygenase inhibitor that induces apoptosis in human tumour cells. J Nutr 2001; 131 (Suppl): 196s (Abstr 1).
15. Cobb C, Ernst E. Systematic review of a marine nutriceutical supplement in clinical trials for arthritis: the effectiveness of the New Zealand green-lipped mussel Perna canaliculus. Clin Rheumatol 2006; 25(3): 275-284.
16. Emelyanov A, Fedoseev G, Krasnoschekova O et al. Treatment of asthma with lipid extract of New Zealand green-lipped mussel: a randomised clinical trial. Eur Respir J 2002; 20(3): 596-600.
17. Health: Mussel Offers Cancer Hope. http://news.bbc.co.uk/1/hi/health/ 409147.stm (1 May 2009, date last accessed).